Health Care International - Preliminary Data From Ongoing Phase 1 Data Of Investigational Anti-PD-1 Antibody Presented At American Society Of Clinical Oncology Annual Meeting
Medarex, Inc. (Nasdaq: MEDX) announced preliminary data from an ongoing Phase 1 study of MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody. Data presented from patients with recurrent or trea
Comments